Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Materialise Brings 3D Printing to Plan CV Surgery at Fuwai Hospital

publication date: Jun 25, 2015
Materialise, a 3D printing company based in Belgium, agreed to open a multidisciplinary 3D printing center in Fuwai Hospital, a tier three Beijing hospital focused on cardiovascular care. The center will use Materialise's HeartPrint® software and printing equipment to construct 3D models of patients' hearts, based on MRI and CT scans, The models will help surgeons plan their strategy before complex surgeries. Materialise expects Fuwai Hospital will introduce the technology to the rest of China. More details....

Stock Symbol: (NSDQ: MTLS)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital